Schöber C - Search Results

1

Differential effect of GM-CSF and G-CSF in cyclic neutropenia.

Freund MR, Luft S, Schöber C, Heussner P, Schrezenmaier H, Porzsolt F, Welte K. Freund MR, et al. Among authors: schober c. Lancet. 1990 Aug 4;336(8710):313. doi: 10.1016/0140-6736(90)91849-6. Lancet. 1990. PMID: 1695985 No abstract available.

2

A phase II study of high dose tamoxifen in progressive, metastatic renal cell carcinoma.

Stahl M, Wilke H, Schmoll HJ, Schöber C, Diedrich H, Casper J, Freund M, Poliwoda H. Stahl M, et al. Among authors: schober c. Ann Oncol. 1992 Feb;3(2):167-8. doi: 10.1093/oxfordjournals.annonc.a058136. Ann Oncol. 1992. PMID: 1606089 Free article. Clinical Trial.

3

Folinic acid (FA) plus 5-fluorouracil (FU) in progressive advanced colorectal cancer.

Wilke H, Schmoll HJ, Schöber C, Stahl M, Preusser P, Freund M, Poliwoda H. Wilke H, et al. Among authors: schober c. Biomed Pharmacother. 1988;42(6):373-80. Biomed Pharmacother. 1988. PMID: 3064821 Review.

4

Folinic acid (CF)/5-fluorouracil (FUra) combinations in advanced gastrointestinal carcinomas.

Wilke H, Schmoll HJ, Preusser P, Fink U, Stahl M, Schöber C, Link H, Freund M, Hanauske A, Meyer HJ, et al. Wilke H, et al. Among authors: schober c. Adv Exp Med Biol. 1988;244:233-43. doi: 10.1007/978-1-4684-5607-3_25. Adv Exp Med Biol. 1988. PMID: 3073658 Clinical Trial. No abstract available.

5

A 3-day schedule of 5-fluorouracil and folinic acid in metastatic progressive colorectal cancer and its impact in terms of palliation.

Schöber C, Köhne-Wömpner CH, Schmoll HJ, Stahl M, Wilke HJ, Poliwoda H. Schöber C, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):136-40. Semin Oncol. 1992. PMID: 1557639 Clinical Trial.

6

Cisplatin, etoposide, and ifosfamide salvage therapy for refractory or relapsing germ cell carcinoma.

Harstrick A, Schmoll HJ, Wilke H, Köhne-Wömpner CH, Stahl M, Schöber C, Casper J, Bruderek L, Schmoll E, Bokemeyer C, et al. Harstrick A, et al. Among authors: schober c. J Clin Oncol. 1991 Sep;9(9):1549-55. doi: 10.1200/JCO.1991.9.9.1549. J Clin Oncol. 1991. PMID: 1651992

7

High dose epirubicin in refractory or relapsed non-seminomatous testicular cancer: a phase II study.

Harstrick A, Schmoll HJ, Wilke H, Schöber C, Stahl M, Wömpner CK, Bokemeyer C, Dölken G, Burk K, Poliwoda H. Harstrick A, et al. Among authors: schober c. Ann Oncol. 1990 Sep;1(5):375-6. doi: 10.1093/oxfordjournals.annonc.a057778. Ann Oncol. 1990. PMID: 2261377 Free article. Clinical Trial.

8

Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours.

Schöber C, Schmoll E, Schmoll HJ, Poliwoda H, Schuppert F, Stahl M, Bokemeyer C, Wilke H, Weiss J. Schöber C, et al. Eur J Cancer. 1992;28A(10):1664-6. doi: 10.1016/0959-8049(92)90064-9. Eur J Cancer. 1992. PMID: 1382494

9

The role of schedule dependency of 5-fluorouracil/leucovorin combinations in advanced colorectal cancer.

Schöber C, Bokemeyer C, Stahl M, Wilke HJ, Schmoll HJ, Poliwoda H. Schöber C, et al. Semin Oncol. 1992 Apr;19(2 Suppl 3):131-5. Semin Oncol. 1992. PMID: 1557638

10

Modulation of cytotoxic drug activity by dipyridamole.

Schmoll HJ, Harstrick A, Köhne-Wömpner CH, Schöber C, Wilke H, Poliwoda H. Schmoll HJ, et al. Among authors: schober c. Cancer Treat Rev. 1990 Dec;17 Suppl A:57-65. doi: 10.1016/0305-7372(90)90017-a. Cancer Treat Rev. 1990. PMID: 2092872 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75 results

Search Page